Prolonged QTc interval in association with medium-chain acyl-coenzyme A dehydrogenase deficiency

Pediatrics. 2014 Jun;133(6):e1781-6. doi: 10.1542/peds.2013-1105. Epub 2014 May 5.

Abstract

Medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency is the most common disorder of mitochondrial fatty acid oxidation. We report a term male infant who presented at 3 days of age with hypoglycemia, compensated metabolic acidosis, hypocalcemia, and prolonged QTc interval. Pregnancy was complicated by maternal premature atrial contractions and premature ventricular contractions. Prolongation of the QTc interval resolved after correction of metabolic derangements. The newborn screen was suggestive for MCAD deficiency, a diagnosis that was confirmed on genetic analysis that showed homozygosity for the disease-associated missense A985G mutation in the ACADM gene. This is the first report of acquired prolonged QTc in a neonate with MCAD deficiency, and it suggests that MCAD deficiency should be considered in the differential diagnoses of acute neonatal illnesses associated with electrocardiographic abnormality. We review the clinical presentation and diagnosis of MCAD deficiency in neonates.

Keywords: MCAD; medium-chain acyl-coenzyme A dehydrogenase deficiency; neonate; prolonged QT.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Acyl-CoA Dehydrogenase / deficiency*
  • Acyl-CoA Dehydrogenase / genetics
  • Diagnosis, Differential
  • Diazepam Binding Inhibitor / genetics
  • Electrocardiography
  • Homozygote
  • Humans
  • Infant
  • Infant, Newborn
  • Lipid Metabolism, Inborn Errors / diagnosis*
  • Lipid Metabolism, Inborn Errors / genetics
  • Long QT Syndrome / diagnosis*
  • Long QT Syndrome / genetics
  • Male
  • Mutation, Missense / genetics
  • Neonatal Screening

Substances

  • Diazepam Binding Inhibitor
  • Acyl-CoA Dehydrogenase

Supplementary concepts

  • Medium chain acyl CoA dehydrogenase deficiency